A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females
Phase of Trial: Phase IV
Latest Information Update: 11 Mar 2019
Price : $35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms CONFIRM
- Sponsors C.R. Bard
- 05 Mar 2019 Status changed from recruiting to discontinued.
- 24 Apr 2018 Status changed from not yet recruiting to recruiting.
- 27 Feb 2018 Planned number of patients changed from 160 to 165.